RGIYX
Price
$9.86
Change
+$0.10 (+1.02%)
Updated
Apr 24 closing price
Net Assets
344.63M
VCRQX
Price
$13.97
Change
+$0.07 (+0.50%)
Updated
Apr 24 closing price
Net Assets
886.92M
Ad is loading...

RGIYX vs VCRQX

Header iconRGIYX vs VCRQX Comparison
Open Charts RGIYX vs VCRQXBanner chart's image
Russell Inv Global Infrastructure Y
Price$9.86
Change+$0.10 (+1.02%)
VolumeN/A
Net Assets344.63M
NYLI CBRE Global Infrastructure Class R6
Price$13.97
Change+$0.07 (+0.50%)
VolumeN/A
Net Assets886.92M
RGIYX vs VCRQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGIYX vs. VCRQX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGIYX is a Buy and VCRQX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VCRQX has more cash in the bank: 887M vs. RGIYX (345M). RGIYX pays higher dividends than VCRQX: RGIYX (3.07) vs VCRQX (1.89). RGIYX was incepted earlier than VCRQX: RGIYX (15 years) vs VCRQX (5 years). RGIYX (1.04) is less costly to investors than VCRQX (0.92). RGIYX is a more actively managed with annual turnover of: 67.00 vs. VCRQX (47.00). VCRQX has a lower initial minimum investment than RGIYX: VCRQX (0) vs RGIYX (10000000). VCRQX annual gain was more profitable for investors over the last year : 17.78 vs. RGIYX (15.99). VCRQX return over 5 years is better than : 49.76 vs. RGIYX (30.42).
RGIYXVCRQXRGIYX / VCRQX
Total Expense Ratio0.830.9290%
Annual Report Gross Expense Ratio1.040.92113%
Fund Existence15 years5 years-
Gain YTD8.0927.326110%
Front LoadN/AN/A-
Min. Initial Investment100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets345M887M39%
Annual Yield % from dividends3.071.89162%
Returns for 1 year15.9917.7890%
Returns for 3 years12.8011.05116%
Returns for 5 years30.4249.7661%
Returns for 10 years-10.87N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCSDX39.260.63
+1.63%
NYLI WMC Enduring Capital Class R6
ENHCX9.990.04
+0.40%
Cullen Enhanced Equity Income C
FBTTX22.41N/A
N/A
Fidelity Advisor Biotechnology M
HCPIX94.86N/A
N/A
ProFunds UltraSector Health Care Inv
LAFCX17.97N/A
N/A
Lord Abbett Affiliated C